Against the hype
San Francisco, 6 December 2018 – Artificial Intelligence (AI) seems to be everywhere and with applications in almost all fields of modern science.
RETHINK fellow Dr. Jan Hiss took the participants of the WORLDWEBFORUM on a journey to the world of molecules.
AI is back — this time, apparently, for good. The combination of laboratory automation and innovative software solutions for process planning and drug design promises better drugs, discovered and delivered faster
RETHINKING Drug Design
Read all about the “rETHinking Drug Design with Artificial Intelligence” Workshop in San Francisco.
Who we are and what we do
RETHINK is a future-oriented non-commercial, non-partisan think-and-do tank of ETH Zurich for design thinking with artificial intelligence.